Success Story: Two Approvals, One Journey: Iranian Postdoc Earns NIW & EB1A - EB1A in Just 11 Days!
Client’s Testimonial:
“Thank you very much for your outstanding support throughout this journey.”
On October 2nd, 2024, and June 13th, 2025, we received another EB-2 NIW (National Interest Waiver) and EB-1A (Alien of Extraordinary Ability) approvals for a Postdoctoral Associate in the Field of Diagnostic Biomarkers (Approval Notice).
General Field: Diagnostic Biomarkers
Position at the Time of Case Filing: Postdoctoral Associate
Country of Origin: Iran
State of Residence at the Time of Filing: Massachusetts
Approval Notice Date: : October 2nd, 2024 (NIW); June 13th, 2025 (EB1A)
Processing Time: 9 months, 19 days (NIW), and 11 days (EB1A – Premium Processing Requested)
Case Summary:
We are thrilled to announce the approval of both the National Interest Waiver (NIW) and EB1A I-140 petitions for a highly accomplished medical researcher specializing in diagnostic biomarkers. The NIW petition was approved in October 2024, followed by EB1A approval under premium processing in June 2025. These decisions reflect the extraordinary impact of the petitioner’s contributions to neuropsychiatry, cancer research, radiology, and pain diagnostics.
Innovating at the Intersection of Medicine, Imaging, and AI
With an M.D. and extensive clinical research experience, the petitioner is recognized as one of the few leading specialists in the diagnostic biomarkers field. He is particularly known for leveraging neuroimaging, nanotechnology, and artificial intelligence to develop precise diagnostic and therapeutic tools for neuropsychiatric disorders, cancer, chronic pain, and COVID-19 complications.
Currently conducting translational research in a prominent U.S. medical setting, the petitioner’s ongoing projects include the integration of high-field MRI, brain stimulation technologies, and radiomic modeling, paving the way for more personalized and predictive healthcare.
A Substantial Record of Scientific Impact
At the time of filing, the petitioner had authored:
- 33 peer-reviewed journal articles,
- 7 preprints,
- 2 published and 1 accepted book chapters,
- 3 abstracts.
His publications had been cited 376 times, with at least 7 articles ranking in the top 1–10% most cited in clinical medicine for their year. In addition, he has completed 30+ peer reviews for top journals and serves on editorial boards for multiple international publications in neuroscience and imaging.
International Expert Support and Recognition
The petition was accompanied by seven letters of recommendation, including five from independent recommenders affiliated with leading academic and clinical institutions across the U.S. and Europe. These letters emphasized the originality, relevance, and global applicability of the petitioner’s work.
“It is extremely noteworthy that [Client] has been asked to perform these duties on multiple occasions, and this positively confirms his elevated standing in the field of diagnostic biomarkers.”
Transforming U.S. Public Health and Scientific Leadership
Through highly cited research and practical innovations in AI-driven diagnostics, neuromodulation, and pain management, the petitioner’s work contributes directly to national priorities in healthcare, precision medicine, and pandemic response. His approvals under both NIW and EB1A underscore the lasting value of his expertise to U.S. scientific advancement.
We are honored to support such an impactful researcher and look forward to his continued success.